This company seems to have been delisted
Reason: Acquired by Ipsen
Last recorded trade on: May 5, 2023
Source: https://www.ipsen.com/press-releases/ipsen-completes-acquisition-of-albireo-expanding-the-scope-of-its-rare-disease-portfolio/
Reason: Acquired by Ipsen
Last recorded trade on: May 5, 2023
Source: https://www.ipsen.com/press-releases/ipsen-completes-acquisition-of-albireo-expanding-the-scope-of-its-rare-disease-portfolio/
Albireo Pharma
ALBO
₹3,826
Share price
0.00%
Change (1 day)
126.46%
Change (1 year)
Categories
Market capitalization of Albireo Pharma (ALBO)
Last known market cap: ₹79.36 Billion
On May 5, 2023 Albireo Pharma had a market cap of ₹79.36 Billion. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Albireo Pharma from 2007 to 2023
End of year Market Cap
| Year | Marketcap | Change |
|---|---|---|
| 2023 | ₹76.24 B | 105.97% |
| 2022 | ₹37.01 B | 10.67% |
| 2021 | ₹33.45 B | -36.18% |
| 2020 | ₹52.41 B | 126.8% |
| 2019 | ₹23.11 B | 12.57% |
| 2018 | ₹20.53 B | 41.14% |
| 2017 | ₹14.54 B | 91.87% |
| 2016 | ₹7.58 B | 419.11% |
| 2015 | ₹1.46 B | -26.12% |
| 2014 | ₹1.97 B | -33.39% |
| 2013 | ₹2.96 B | 62.7% |
| 2012 | ₹1.82 B | 46.04% |
| 2011 | ₹1.24 B | -42.37% |
| 2010 | ₹2.16 B | -54.93% |
| 2009 | ₹4.80 B | -12.45% |
| 2008 | ₹5.49 B | -70.29% |
| 2007 | ₹18.49 B |
Market capitalization for similar companies or competitors
| Name | Marketcap | Market cap differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | ₹84.47 B | 6.44% | 🇺🇸 USA |